Clinical trial
A Randomized, Placebo-Controlled, Double-Blind Study of the Effects of Magnesium Compared to Conventional Therapy on Acute Migraine
NCT05967442 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-Controlled, Double-Blind Study of the Effects of Magnesium Compared to Conventional Therapy on Acute Migraine
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 23, 2019
- Completion date
- April 6, 2023
- Enrollment
- 157 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
headache, migraine